Nanoform Finland Limited is a nanoparticle medicine enabling company that works with global pharma and biotech partners to enhance their drug molecules through its nanonization services.

Nanoform’s Controlled Expansion of Supercritical Solutions (CESS) technology produces nanonized 'designed-for-purpose' API particles, as small as 10nm. This enables poorly soluble molecules in the pharmaceutical pipeline to progress into clinical development by increasing their rate of dissolution and improving their bioavailability. The unique technology also provides novel opportunities in diverse value enhancing drug delivery applications.


Find Nanoform on LinkedIn

Contact Info